Pfizer

News

Blood sample with respiratory coronavirus positive

UK announces COVID-19 vaccine deals with BioNTech/Pfizer and...

The UK has secured 90 million doses of two different COVID-19 vaccines from BioNTech/Pfizer and Valneva, with an option of 40 million doses if they check out in trials.

News

J&J's Tremfya to join crowded psoriatic arthritis market aft...

The FDA has approved a label extension for Johnson & Johnson’s Tremfya (guselkumab) in psoriatic arthritis, the first drug from the IL-23 class to gain a foothold in this indication.

News

FDA to fast track development of two COVID-19 vaccines from ...

Two of Pfizer and BioNTech’s potential COVID-19 vaccines have been granted Fast Track status by the FDA, a process designed to hasten their development and review.

News

Pharma companies create $1bn fund to save antibiotic researc...

More than 20 pharma companies including GlaxoSmithKline, Novartis and Pfizer have joined forces to create a $1 billion fund to save the pipeline of antibiotics drugs, after several biotechs

News

EU regulators approve AstraZeneca's Lynparza in pancreatic c...

The European Commission has approved AstraZeneca and MSD’s Lynparza (olaparib) in pancreatic cancer patients with a certain mutation.

News

Pfizer/BioNTech's COVID-19 vaccine neutralises virus in earl...

Pfizer and BioNTech have announced early results from their ongoing phase 1 /2 study of a potential COVID-19 coronavirus vaccine, showing the jab seems to be working in a small sample of pa

UK announces COVID-19 vaccine deals with BioNTech/Pfizer and...

J&J's Tremfya to join crowded psoriatic arthritis market aft...

FDA to fast track development of two COVID-19 vaccines from ...

Pharma companies create $1bn fund to save antibiotic researc...

EU regulators approve AstraZeneca's Lynparza in pancreatic c...

Pfizer/BioNTech's COVID-19 vaccine neutralises virus in earl...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks